It has been proposed that the downregulation of steroyl-CoA response element binding protein-1c (SREBP-1c), a de novo lipogenesis related transcriptional regulator could improves the non-alcoholic stetatohepatitis (NASH) [41,42]. Here, SREBF1 is linked to metabolic dysfunction-associated steatohepatitis.